| Romero B, García-Martínez MA, Solera M, et al.
[Re-administration of drotrecogin alpha.] [Journal Article]
Med Intensiva 2009 Jun-Jul; 33(5):261-2.
Full Citation | Publisher Full Text |
| Ahishakiye D, Lorent S, De Backer D, et al.
Drotrecogin alfa (activated) for severe sepsis: Could we consider a shorter treatment period in patients with a favorable course? [JOURNAL ARTICLE]
J Crit Care 2009 Jul 2.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Martin G, Brunkhorst FM, Janes J, et al.
The international PROGRESS registry of patients with severe sepsis: drotrecogin alfa (activated) use and patient outcomes. [JOURNAL ARTICLE]
Crit Care 2009 Jun 30; 13(3):R103.
Abstract | Full Citation | Find Related Articles |
| Vieillard-Baron A, Caille V, Charron C, et al.
Reversal of refractory septic shock with drotrecogin alpha (activated). [Journal Article]
Intensive Care Med 2009 Jul; 35(7):1204-9.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Garber K
Ariad's NFkappaB patent claims shot down on appeal. [News]
Nat Biotechnol 2009 Jun; 27(6):494-5.
Full Citation | Publisher Full Text | Find Related Articles |
| Mann HJ, Short MA, Schlichting DE
Protein C in critical illness. [Journal Article]
Am J Health Syst Pharm 2009 Jun 15; 66(12):1089-96.
Abstract | Full Citation | Publisher Full Text |
| Teschendorf P, Padosch SA, Del Valle Y Fuentes D, et al.
Effects of activated protein C on postcardiac arrest microcirculation: An in vivo microscopy study. [JOURNAL ARTICLE]
Resuscitation 2009 May 30.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Hodder RV, Hall R, Russell JA, et al.
Early drotrecogin alpha (activated) administration in severe sepsis is associated with lower mortality: a retrospective analysis of the Canadian ENHANCE cohort. [JOURNAL ARTICLE]
Crit Care 2009 May 20; 13(3):R78.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Lorenz BD, Smith TD, Laessig K, et al.
Recombinant activated protein C and risk of bleeding. [Comment, Letter]
Crit Care Med 2009 Jun; 37(6):2141-2; author reply 2142.
Full Citation | Publisher Full Text | Find Related Articles |
| Williams M, Janes J
Recombinant activated protein C and risk of bleeding. [Comment, Letter]
Crit Care Med 2009 Jun; 37(6):2140-1; author reply 2142.
Full Citation | Publisher Full Text | Find Related Articles |
   |
